Clearpoint Cash And Short Term Investments from 2010 to 2024
| CLPT Stock | USD 11.67 0.17 1.44% |
Cash And Short Term Investments | First Reported 2011-12-31 | Previous Quarter 32.8 M | Current Value 21.6 M | Quarterly Volatility 17.8 M |
Check Clearpoint Neuro financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Clearpoint Neuro's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.5 M, Interest Expense of 366.7 K or Selling General Administrative of 7.5 M, as well as many indicators such as Price To Sales Ratio of 7.13, Dividend Yield of 0.0 or PTB Ratio of 8.29. Clearpoint financial statements analysis is a perfect complement when working with Clearpoint Neuro Valuation or Volatility modules.
Clearpoint | Cash And Short Term Investments |
Latest Clearpoint Neuro's Cash And Short Term Investments Growth Pattern
Below is the plot of the Cash And Short Term Investments of Clearpoint Neuro over the last few years. Short Term Investments is an account in the current assets section of Clearpoint Neuro balance sheet. This account contains Clearpoint Neuro investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Clearpoint Neuro fairly quickly. It is the sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash. Clearpoint Neuro's Cash And Short Term Investments historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Clearpoint Neuro's overall financial position and show how it may be relating to other accounts over time.
| Cash And Short Term Investments | 10 Years Trend |
|
Cash And Short Term Investments |
| Timeline |
Clearpoint Cash And Short Term Investments Regression Statistics
| Arithmetic Mean | 12,748,413 | |
| Geometric Mean | 5,139,563 | |
| Coefficient Of Variation | 120.91 | |
| Mean Deviation | 11,466,925 | |
| Median | 5,695,722 | |
| Standard Deviation | 15,413,618 | |
| Sample Variance | 237.6T | |
| Range | 54M | |
| R-Value | 0.68 | |
| Mean Square Error | 137.7T | |
| R-Squared | 0.46 | |
| Significance | 0.01 | |
| Slope | 2,342,638 | |
| Total Sum of Squares | 3326.1T |
Clearpoint Cash And Short Term Investments History
About Clearpoint Neuro Financial Statements
Clearpoint Neuro shareholders use historical fundamental indicators, such as Cash And Short Term Investments, to determine how well the company is positioned to perform in the future. Although Clearpoint Neuro investors may analyze each financial statement separately, they are all interrelated. The changes in Clearpoint Neuro's assets and liabilities, for example, are also reflected in the revenues and expenses on on Clearpoint Neuro's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Cash And Short Term Investments | 23.1 M | 14.9 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Clearpoint Stock Analysis
When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.